Co-Authors
This is a "connection" page, showing publications co-authored by Faryal Khamis and Zaiyana Ambusaidi.
Connection Strength
0.288
-
Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia. Int J Infect Dis. 2021 Jan; 102:538-543.
Score: 0.228
-
Immunological predictors of disease severity in patients with COVID-19. Int J Infect Dis. 2021 Sep; 110:83-92.
Score: 0.060